BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25713304)

  • 1. Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-α/ASK1/JNK pathway.
    Wu QQ; Xu M; Yuan Y; Li FF; Yang Z; Liu Y; Zhou MQ; Bian ZY; Deng W; Gao L; Li H; Tang QZ
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1143-54. PubMed ID: 25713304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsins in heart disease-chewing on the heartache?
    Blondelle J; Lange S; Greenberg BH; Cowling RT
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H974-6. PubMed ID: 25747750
    [No Abstract]   [Full Text] [Related]  

  • 3. Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.
    Liu X; Yang Q; Zhu LH; Liu J; Deng KQ; Zhu XY; Liu Y; Gong J; Zhang P; Li S; Xia H; She ZG
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29945911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension.
    Meijles DN; Cull JJ; Markou T; Cooper STE; Haines ZHR; Fuller SJ; O'Gara P; Sheppard MN; Harding SE; Sugden PH; Clerk A
    Hypertension; 2020 Oct; 76(4):1208-1218. PubMed ID: 32903101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
    Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
    Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1.
    Fan GC; Yuan Q; Song G; Wang Y; Chen G; Qian J; Zhou X; Lee YJ; Ashraf M; Kranias EG
    Circ Res; 2006 Nov; 99(11):1233-42. PubMed ID: 17068291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cathelicidin-related antimicrobial peptide suppresses cardiac hypertrophy induced by pressure overload by regulating IGFR1/PI3K/AKT and TLR9/AMPKα.
    Wang X; Chen L; Zhao X; Xiao L; Yi S; Kong Y; Jiang Y; Zhang J
    Cell Death Dis; 2020 Feb; 11(2):96. PubMed ID: 32029708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IcarisideII improves left ventricular remodeling in spontaneously hypertensive rats by inhibiting the ASK1-JNK/p38 signaling pathway.
    Wu Y; Qian Z; Fu S; Yue Y; Li Y; Sun R; Huang B; Yang D
    Eur J Pharmacol; 2018 Jan; 819():68-79. PubMed ID: 29175071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
    Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
    Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice.
    Liu Q; Sargent MA; York AJ; Molkentin JD
    Circ Res; 2009 Nov; 105(11):1110-7. PubMed ID: 19815822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice.
    Ye Y; Gong H; Wang X; Wu J; Wang S; Yuan J; Yin P; Jiang G; Li Y; Ding Z; Zhang W; Zhou J; Ge J; Zou Y
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):628-39. PubMed ID: 25806688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy.
    Sadoshima J; Montagne O; Wang Q; Yang G; Warden J; Liu J; Takagi G; Karoor V; Hong C; Johnson GL; Vatner DE; Vatner SF
    J Clin Invest; 2002 Jul; 110(2):271-9. PubMed ID: 12122119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.
    Liu J; Liu X; Hui X; Cai L; Li X; Yang Y; Shu S; Wang F; Xia H; Li S
    J Am Heart Assoc; 2019 Aug; 8(16):e011830. PubMed ID: 31426686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1-P38/c-JUN N-Terminal Kinase 1/2 Signaling.
    Huang Z; Shu J; Jiang W; Jiang M; Lu Y; Dai H; Xu N; Yuan H; Cai J
    J Am Heart Assoc; 2018 Oct; 7(19):e009179. PubMed ID: 30371330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinnamaldehyde attenuates pressure overload-induced cardiac hypertrophy.
    Yang L; Wu QQ; Liu Y; Hu ZF; Bian ZY; Tang QZ
    Int J Clin Exp Pathol; 2015; 8(11):14345-54. PubMed ID: 26823750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha and apoptosis signal-regulating kinase 1 control reactive oxygen species release, mitochondrial autophagy, and c-Jun N-terminal kinase/p38 phosphorylation during necrotizing enterocolitis.
    Baregamian N; Song J; Bailey CE; Papaconstantinou J; Evers BM; Chung DH
    Oxid Med Cell Longev; 2009; 2(5):297-306. PubMed ID: 20716917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc Finger Protein ZBTB20 protects against cardiac remodelling post-myocardial infarction via ROS-TNFα/ASK1/JNK pathway regulation.
    Li F; Yang Y; Xue C; Tan M; Xu L; Gao J; Xu L; Zong J; Qian W
    J Cell Mol Med; 2020 Nov; 24(22):13383-13396. PubMed ID: 33063955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.
    Chen G; Pan SQ; Shen C; Pan SF; Zhang XM; He QY
    Acta Pharmacol Sin; 2014 Apr; 35(4):463-75. PubMed ID: 24608673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy.
    Zheng RH; Zhang WW; Ji YN; Bai XJ; Yan CP; Wang J; Bai F; Zhao ZQ
    Eur J Pharmacol; 2020 Sep; 883():173318. PubMed ID: 32621911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.